Fuller & Thaler Asset Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q3 | – | Sell |
-59,991
| Closed | -$5.84M | – | 801 |
|
|
2015
Q2 | $5.84M | Buy |
59,991
+1,258
| +2% | +$122K | 0.16% | 112 |
|
|
2015
Q1 | $5.49M | Sell |
58,733
-191
| -0.3% | -$17.9K | 0.18% | 123 |
|
|
2014
Q4 | $5.24M | Buy |
58,924
+877
| +2% | +$78K | 0.19% | 126 |
|
|
2014
Q3 | $4.01M | Hold |
58,047
| – | – | 0.17% | 144 |
|
|
2014
Q2 | $3.33M | Sell |
58,047
-8,655
| -13% | -$496K | 0.14% | 170 |
|
|
2014
Q1 | $2.65M | Sell |
66,702
-7,753
| -10% | -$307K | 0.13% | 187 |
|
|
2013
Q4 | $3.12M | Buy |
+74,455
| New | +$3.12M | 0.17% | 173 |
|